Leila Khalili, MSN, FNP, APRN
Columbia University Medical Center
New York, New York, United States
Disclosure(s): UCB: Consultant (Terminated, May 2, 2024)
Donna McArthur, PhD, FNP, APRN
Eosinophilic & Rare Disease Cooperative
Tucson, Arizona, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Joshua Stefanik, PhD, PT
Northeastern University
Boston, Massachusetts, United States
Disclosure information not submitted.
This robust panel focuses on the challenges patients with vasculitis and other rare diseases face in disclosing certain symptoms and health concerns to their healthcare providers. The discussion highlights issues such as embarrassment, denial, and fear of potential consequences as barriers to open communication between patients and their care team. When a provider is only offered a selection of information, they are operating with subpar data from which to develop a treatment plan. The panel, consisting of a couple patients, care partner, physician and social worker, will explore the challenges in creating a truly trusting environment in which patients do not withhold important information about QoL and the impact of disease. Attendees will develop strategies to create a trusting environment and ensure that the patient/provider partnership is functioning optimally. Additionally, attendees will learn underlying psychosocial factors that impact transparency and sharing. Finally, a survey of vasculitis patients will be presented to provide real-world examples and data about information being withheld that might impact treatment planning or patient engagement in plan follow through.
Speaker: Sarah Jones, MS, MPA (she/her/hers) – Eosinophilic & Rare Disease Cooperative
Speaker: Alicia Rodriguez-Pla, MD,PhD,RhMSUS,MPH,FACP – Sierra Pacific Arthritis and Rheumatology Centers